Announced Sat, 7 Feb · 15:29 IST

Nexus Surgical And Medicare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2026 ,inter alia, to consider and approve 1. Unaudited quarterly ....

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Nexus Surgical and Medicare Ltd has informed BSE that a Board Meeting is scheduled on 14th February 2026 at 3:30 p.m. at its registered office in Vasai (East), Palghar. The key agenda item is to consider and approve the unaudited financial results for the quarter ended 31st December 2025 (Q3 FY26). Any other business with the Chair's permission may also be taken up. The trading window for designated persons remains closed till 16th February 2026, in line with standard pre-results insider trading norms.

Likely market impact

This is a routine regulatory filing; no material action for investors yet. The actual results on 14th February will be the key catalyst — watch for revenue growth, margins, and profit trends in the healthcare/medical device segment.